Biologics

Bioventus Extends Distribution Agreement for SUPARTZ FX™

July 01, 2016

 

DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has entered into an agreement with Seikagaku Corporation to continue distributing SUPARTZ FXin the US after the current distribution agreement expires in May 2017. Under terms of this extension, Bioventus will continue to distribute SUPARTZ FX in the US through May 2019.

“We are pleased that Bioventus will continue to provide physicians and patients with SUPARTZ FX beyond 2017,” said Tony Bihl, CEO of Bioventus. “HA products like SUPARTZ FX underscore our mission to help people resume and enjoy active lives.”

About Bioventus

Bioventus LLC is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical that make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.

For more information, visit www.BioventusGlobal.com and follow the company on Twitter @Bioventusglobal

SUPARTZ FX – Summary of Indications for Use:

Indications for use: SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.

You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to avian (bird) products (feathers and eggs). SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site. Full prescribing information can be found in product labeling, at www.SupartzFX.com or by contacting customer service at 1-800-836-4080.

Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC. SUPARTZ FX is a trademark of Seikagaku.

Contacts

Bioventus LLC
Thomas Hill, 919-474-6715
thomas.hill@bioventusglobal.com

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button